EMA Information Day on Risk Management Planning

Pharmacovigilance guidelines (GVP) in special populations, i.e. children, older patients and women concerning pregnancy and breastfeeding, are currently being developed. The RMP Info Day will offer the opportunity to share the current status of the guidelines with a special emphasis on the impact of new guidelines on medicines risk management in these populations. Furthermore, this will be an opportunity to solicit input from stakeholders for further development specifically of the GVP on older people to enhance medicines’ safety in the geriatric population.